ibrutinib,venetoclax
abbvie,janssen,roche
['cll', 'venetoclax', ' ibru']
addition of ven to pts on ibrutinib in high risk cll pts. #ash22 
Assistant Professor at UNC Eshelman School of Pharmacy. #adherence, #leukemia, #globalhealth, #access, #impsci, #equity